Clinical Trials Browser

Completed × Oropharyngeal Neoplasms × Nivolumab × Clear all

NCT03838263 2025-03-04

IMMUNEBOOST

Phase 2 Completed

Oropharyngeal Neoplasms

NCT03715946 2025-01-13

Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer

Phase 2 Completed

40 enrolled 69 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms